I 1. Under hormonally constant conditions, the effects of a sudden increase in blood pressure on the release of endothelium-derived relaxing factor were evaluated by measuring urinary excretion of NO;/NO; in rats with renal denervation. 2. Elevation of blood pressure from 1 3 6 k 2 to 1 5 3 k 3 mmHg by an aortic clamp below the renal arteries induced a significant increase in urinary excretion of NO;/NO; from 76.6 k4.2 x 10' to 108.1 k 8.3 x 10' pmol min-' g-' kidney weight (P< 0.05).
INTRODUCTION
Accumulating evidence suggests that the vascular endothelium is primarily responsible for modulation of the vascular tone through the release of endotheliumderived relaxing factor (EDRF) [l-41. Although the release and/or synthesis of EDRF is known to be stimulated by several stimuli [5] , including physical forces, hormones and nerves, it has not been clarified as to in what situation in vivo EDRF is released.
Currently, EDRF is identified as NO and measurements of NO may represent the synthesis and/or release of EDRF [5-71. However, since NO is degraded extremely rapidly to NO;/NO; and a direct assay for NO;/NO; in the blood of rats is not yet available, measurement of NO;/NO; in the urine is suggested as an indicator of the release of EDRF [ 5 ] .
In the present study, in order to evaluate the release of EDRF during sudden increases in transmural pressure, we measured NO;/NO.; in the urine under hormonally and neurally constant conditions. In addition, NG-monomethyl-L-arginine ( L-NMMA) was used to inhibit EDRF formation [8] .
MATERIALS AND METHODS

Animals and protocol
Experiments were carried out on 22 male adult Wistar-Kyoto rats weighing around 260 g. All rats were fed on rat chow containing 0.38% sodium by weight and were allowed to drink water ad libitum.
Experiments were performed on uninephrectomized bilaterally adrenectomized and unilaterally denervated rats. The left kidney was denervated with a 10% (w/v) solution of phenol in ethanol. The surgical preparations were basically similar to those described previously [9, lo] . Rats were anaesthetized with Inactin (100 mg/kg, intraperitoneal injection) and were placed on a warm plate to maintain body temperature at 36°C. The left carotid artery was cannulated to monitor blood pressure with a transducer (TP200T; Nihon Koden, Tokyo, Japan), an amplifier (AP601G; Nihon Koden) and a recorder (WT-685G; Nihon Koden). The left jugular vein was cannulated for the administration of saline (150 mmol/l NaCI) containing 1% (w/v) BSA, noradrenaline (1.0 ng/pl), aldosterone (0.2 ng/pl), hydrocortisone (0.2 pg/pl), vasopressin (0.5 pg/ml), 1% (w/v) inulin and 0.1% p-aminohippurate (PAH) at a rate of 100 pllmin. After laparotomy, another cannula (PE10; Becton and Dickinson Company, NJ, U.S.A.) was placed in the left ureter for the collection of urine. In addition to these procedures, we performed a tracheostomy to facilitate respiration. The operation was completed within 90 min and the infusion was started immediately after cannulation of the jugular vein.
After 60 min of equilibration, urine and plasma were collected over two separate 15 min experimental periods. The values from these two periods were averaged and used as baseline values for analysis.
Experiment I: measurements of N0;INO; excretion in the urine during elevation of blood pressure
One clamp was placed on the aorta below the left renal artery. The aorta was completely occluded by the clamp to increase the renal perfusion pressure. After 15 min of equilibration, clearance studies were performed separately over two 10-1 5 min periods.
Experiment It: effects of L-NMMA on mean arterial pressure, glomerular filtration rate (GFR), renal plasma flow (RPF) and NOTINO; excretion in the urine
One clamp was placed on the aorta below the left renal artery; this was used as a sham procedure. After the baseline clearance studies, L-NMMA (1 mg min-l kg-I) was infused to inhibit the synthesis of EDRF from L-arginine, without any occlusion of the aorta. After 15 min of equilibration, clearance studies were carried out separately over two 10-15 min periods.
Experiment 111: effects of aortic occlusion during infusion of L-NMMA on GFR, RPF and N0;INO; excretion in the urine
Infusion of L-NMMA (1 mg min-I kg-I) was started 15 min before the baseline clearance studies. After the baseline clearance studies and a 15 min interval, the aorta was occluded by the clamp and clearance studies were carried out separately over two 10-15 min periods during the infusion of L-NMMA.
Experiment IV time control
First, the baseline clearance studies were performed. Then, after a 15 min interval, clearance studies were performed separately over two 10-15 min periods. In this experiment, neither occlusion of the clamp nor infusion of L-NMMA was performed.
Analyses
Urine volume was checked by weight, and plasma and urinary sodium concentrations were measured with a flame photometer. GFR and RPF were calculated as the ratio of the urine/plasma concentration of inulin and PAH multiplied by the urine flow rate, respectively. NO;/NO; in urine was measured by an automated system TCI-NOX 1000 (Tokyo Kasei Kogyo Co., Tokyo, Japan) based on colorimetric methods [l 11. The intraassay coefficient of variation was 0.35%.
Statistics
Values are given as means k SEM. The statistical significance of differences was determined by a paired or a nonpaired t-test. A P value of <0.05 was considered significant.
RESULTS
The basal values of body weight and kidney weight are given in Table 1. Table 1 also shows the changes in GFR, RPF and filtration fraction. There were no significant changes in GFR measured before and after the aortic occlusion.
The basal mean arterial pressure averaged 140 mmHg. Before the elevation of blood pressure, the basal value of NO;/NO; excretion in the urine was around 85 x lo2 pmol min-I g-I kidney weight. After elevation of blood pressure by aortic occlusion (Fig. l ) , NO?/NO; excretion in the urine significantly increased to 108 k 8.3 x lo2 pmol min-l g-' kidney weight (1'<0.05, Fig. 2 ). Infusion of L-NMMA caused a significant decrease in NO;/NO; excretion in the urine ( P < 0.05) accompanied by a rise in blood pressure (P<0.05, Figs. 1 and 2 ) . The changes in GFR and RPF during infusion of L-NMMA are summarized in Table 1 . L-NMMA caused a decrease in RPF ( P < 0.05) without a significant change in GFR. During infusion of L-NMMA, the aortic occlusion caused a significant increase in blood pressure without any change in NO;/NO; excretion in the urine (Figs. 1  and 2 ).
DISCUSSION
In the present study, we have demonstrated that, under hormonally controlled conditions, an elevation of blood pressure induced by aortic occlusion caused an increase in the urinary excretion of NO;/NOy in rats with renal denervation. In the present study, rats were prohibited from feeding for at least 12 h and no other apparent factors that would be expected to affect nitrogen metabolism are reported. Although in earlier work [6] a nitratefree diet was used to eliminate the effects of diet on urinary NO;/NO; excretion, we did not employ such a diet. However, in the rats used as time controls, no significant changes in the urinary excretion of NO; /NO; were observed. Therefore, in the present study, the effects of diet on our major findings were eliminated. From these data, it is suggested that elevation of blood pressure is related to the increase in urinary excretion of NO; /NO;.
EDRF is now recognized as NO, which is metabolized and excreted into the urine as NO;/NO;. Our preliminary study [2] revealed that infusion of L-arginine, a precursor of NO, caused an elevation of the urinary excretion of NOJNO,, which was probably due to an increase in the synthesis of EDRF. Therefore, the urinary excretion of NO;/NO; may reflect the synthesis and/or release of EDRF. This hypothesis is supported by the study of Granger et al. [6] .
The release of EDRF has been demonstrated to be stimulated by either shear stress (tangential component) or blood pressure (perpendicular component) [3] . In the system employed in the present study, which component plays the major role in the release of EDRF cannot be exactly determined. Since renal blood flow is not changed, it is less likely that velocity, which is closely related to shear stress, neither increased nor decreased. It is therefore postulated that blood pressure might induce the release of EDRF. Moreover, the system that we employed in this study was originally devised to investigate the pressure-natriuresis mechanism. The most important feature of this system is the maintenance of autoregulation when blood pressure is elevated [9] . From this point of view, it is possible that the release of EDRF contributes to autoregulation.
It is reported that infusion of L-NMMA caused a marked elevation of mean arterial pressure, and it is proposed that NO is constantly generated in the vessel wall to maintain vasodilator tone [7] . Therefore, the inhibition of synthesis of EDRF may have increased the basal blood pressure in the present study. Also, the infusion of L-NMMA induced a decrease NO;/NO; excretion in the urine. Further, aortic occlusion during L-NMMA infusion caused an elevation of blood pressure without any changes in urinary excretion of NO;/NO;. This implies that urinary excretion of NO;/NO; might be an indicator of the release of EDRF. In addition, the infusion of L-NMMA caused a decrease in RPF whereas GFR remained constant. Several lines of evidence suggest that L-NMMA increases renal vascular resistance, whereas GFR remains constant. Our present data accord well with these previous findings [ 121. Further, our data provide evidence that L-NMMA induces vasoconstriction of efferent, but not afferent, arteries [13, 141 , since the filtration fraction was increased significantly.
In conclusion, it is suggested that under hormonally and neurally controlled conditions, elevation of blood pressure per se induces the release of EDRF. Since the question of whether urinary excretion of NO;/NO; reflects systemic vascular or renal vascular generation of EDRF still remains unanswered, further studies will be needed to clarify this point.
